MDNAF
Medicenna Therapeutics Corp.$0.3100 +0.01 (+3.33%)
Oct 27 4:00 PM ET · prev $0.3000
Median target
$4.25
+1271% · range $2.50–6.00
1 year
−73.0%
from $1.15 · Oct 28
30 days
+8.0%
from $0.2870
52-week range
$0.2370–1.19
−74% from high · low Jul 23
Avg volume 20D
62.0K
Oct 6 spike 512.3K
Short interest
527.6K
+6.9%
Days to cover
3.6
at average volume
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- EstimatesRISING
Current-quarter EPS estimate −$0.051 → −$0.036 over 90 days. 2 up, 0 down in 30 days.
- Short sellersSTEADY
Short interest +6.9% to 527.6K shares. 3.6 days to cover.
- TrendUPTREND
2% above its 50-day average.
The Street
last action Dec 202412-month targets · 2 analysts
$0.3100 $2.50 $4.25 $6.00
Price is below the lowest target. Median implies +1271%.Targets as of Oct 28, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Dec 6, 2024 | HC Wainwright & Co. REITERATE | Buy |
| Dec 18, 2020 | Oppenheimer INITIATE | Outperform |
| Dec 17, 2020 | Oppenheimer INITIATE | Outperform |
| Sep 10, 2020 | HC Wainwright & Co. INITIATE | Buy |
Earnings setup
Estimates−$0.04
EPS estimate, this quarter
+29%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
−$0.05190d
−$0.05160d
−$0.04230d
−$0.0427d
−$0.036Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.04 | -$0.04–-$0.04 | +14.3% | $0.00 |
| Next Q | -$0.04 | -$0.04–-$0.04 | +6.0% | $0.00 |
| Current FY | -$0.16 | -$0.16–-$0.15 | +35.1% | $0.00 |
| Next FY | -$0.36 | -$0.79–-$0.13 | -6.3% | $1.3M |
Short side
FINRA· Oct 15, 2026527,629
shares short
+6.9%
vs prior settlement
3.6
days to cover